Pre-earnings options volume in Harrow (HROW) Health is 2.7x normal with calls leading puts 9:4. Implied volatility suggests the market is anticipating a move near 15.2%, or $8.04, after results are released. Median move over the past eight quarters is 17.0%.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HROW:
- HROW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Harrow price target raised to $55 from $45 at Lake Street
- Harrow price target raised to $65 from $45 at Craig-Hallum
- Harrow announces relaunch of TRIESENCE for vitrectomy visualization, inflamation
- Harrow announces expansion of corporate headquarters in Nashville